Prescription Carvedilol recalled for manufacturing impurity exceeding FDA specifications
Glenmark Pharmaceuticals is recalling Carvedilol 25 mg tablets nationwide due to a manufacturing quality issue with impurity levels exceeding FDA recommended limits. Multiple lot numbers and expiration dates from February 2025 through February 2026 are affected.
- Product
- CARVEDILOL — CARVEDILOL (CARVEDILOL)
- Category
- Drug
- Distribution
- Distributed nationwide